6.2 Clinical Appropriateness Checks

6.2 Clinical Appropriateness Checks

Quick Answer: A legally complete prescription can still be clinically inappropriate. Check indication fit, dose for age/weight/organ function, allergies, pregnancy and lactation cues, contraindications, pharmacokinetic and pharmacodynamic interactions, and therapeutic duplication. Use the Australian Medicines Handbook (AMH) as your restricted open-book clinical anchor, and prioritise issues with the greatest risk of harm when time is short.

Standard 3.2.3 expects pharmacists to dispense only when the medicine management plan is appropriate — not merely when the paperwork is filled in. Clinical appropriateness is the second major gate after legal evaluation.

Legal validity ≠ clinical appropriateness

Both gates can independently stop supply or force contact with the prescriber. Passing one does not pass the other.

Indication fit

Ask: Does this medicine make sense for the stated or reasonably inferred indication in this patient?

You will not always receive a written diagnosis on a community prescription. Use available cues:

• Patient history and previous medicines in the dispensing record
• Directions that imply indication (e.g. short antibiotic course vs long-term preventive therapy)
• Age and sex patterns (not stereotypes — cues only)
• Recent discharge summaries, My Health Record (when appropriately accessed), or patient-reported diagnosis

Red flags for indication mismatch:

• Antibiotic regimens that do not match common duration/dose patterns without explanation
• High-risk medicines initiated without monitoring context (e.g. warfarin without INR plan cues)
• Duplicate therapy for the same indication from two prescribers
• Medicines clearly outside usual licensed or guideline use without specialist context

You are not required to diagnose, but you are required to question supply when indication fit is implausible or unsafe.

Dose checks: age, weight, and organ function

Age

• Paediatrics: doses are often weight-based; liquid strengths matter; avoid adult solid forms when inappropriate.
• Older adults: increased sensitivity to anticholinergics, sedatives, antihypertensives, and hypoglycaemics; start-low principles and fall risk matter.
• Neonates and infants: extreme care with concentrations and dropper/mL instructions.

Weight

Weight-based dosing appears in antimicrobials, anticoagulants (some), chemotherapy (specialist), and many paediatric regimens. If weight is needed and unknown, obtain it or clarify rather than guessing adult “standard” doses for children.

Renal function

Many medicines require dose reduction or extension of interval when eGFR/creatinine clearance is reduced (examples commonly tested conceptually: certain antivirals, metformin caution thresholds, some DOAC criteria, renally cleared antibiotics, lithium monitoring context). Look for:

• Documented CKD or dialysis
• Age plus low body weight as risk markers for reduced clearance
• Concurrent nephrotoxins (NSAIDs + ACE inhibitor + diuretic “triple whammy” pattern)

Hepatic function

Hepatic impairment may alter first-pass metabolism, clotting-factor synthesis (warfarin sensitivity), and sedative accumulation. When liver disease is known, check AMH cautions and consider interaction with alcohol use history if relevant to counselling.

Practical dose evaluation steps

1. Read the prescribed dose and frequency carefully (including “as directed” risk).
2. Compare with usual adult/paediatric ranges in AMH.
3. Adjust mental model for renal/hepatic/age extremes.
4. Check maximum daily doses (paracetamol is a classic cumulative toxicity trap).
5. Confirm device-specific dosing (inhalers, insulin units, patches).

If the dose is outside usual range without a clear specialist rationale, contact the prescriber before supply.

Duplicates and therapeutic duplication

Exact duplicate: same medicine already active from another script or recent supply.

Therapeutic duplication: different medicines with the same or overlapping effect, for example:

• Two NSAIDs
• ACE inhibitor plus ARB in routine primary care without specialist justification
• Multiple benzodiazepines or z-drugs
• Duplicate anticoagulants (critical safety issue)
• Multiple anticholinergics increasing cognitive/fall risk

Use the patient’s medication history, not only the single prescription in hand. Community pharmacy software interaction checkers help but do not replace judgement — especially for medicines from multiple pharmacies if history is incomplete.

Interactions: pharmacokinetic and pharmacodynamic

Pharmacokinetic (PK)

PK interactions change concentration: absorption, distribution, metabolism, excretion.

Examples of exam-relevant themes (not an exhaustive list):

• CYP enzyme inhibition/induction affecting object drugs with narrow therapeutic index (e.g. certain anticoagulants, immunosuppressants, anticonvulsants, some antipsychotics)
• P-glycoprotein and transporter effects
• Chelation/binding reducing absorption (e.g. divalent cations with some antibacterials — separate dosing)
• Renal clearance competition or reduced GFR from drug injury

Pharmacodynamic (PD)

PD interactions change effect at similar or related targets:

• Additive QT prolongation risk
• Additive serotonergic effects
• Additive bleeding risk (antiplatelet + anticoagulant + NSAID patterns)
• Additive CNS depression (opioids + benzodiazepines + alcohol)
• Opposing effects (e.g. beta-agonist vs non-selective beta-blocker themes)

Not every software flag is clinically decisive. Prioritise narrow therapeutic index drugs, high-severity interaction monographs in AMH, and combinations known to cause hospitalisation (bleeding, serotonin toxicity, severe hypotension, hypoglycaemia, torsades risk patterns).

Contraindications, allergies, and pregnancy

Contraindications

Absolute contraindications mean do not supply that medicine in that context (unless a highly specialised override exists — rare in routine community stems). Relative contraindications require risk–benefit judgement and often prescriber discussion.

Allergies and hypersensitivities

• Distinguish true allergy (e.g. anaphylaxis to penicillin) from intolerance (nausea).
• Consider cross-reactivity principles (beta-lactams) without over-avoiding whole antibiotic classes when history is mild GI upset only — but never dismiss anaphylaxis history.
• Document allergy status; update records when new information appears.
• Excipients occasionally matter (e.g. some peanut/soya warnings in specific products).

Pregnancy and lactation

When the patient may be pregnant, planning pregnancy, or breastfeeding:

1. Identify medicines with known teratogenic or fetal toxicity concerns (e.g. certain antiepileptics, ACE inhibitors/ARBs, methotrexate, isotretinoin, warfarin themes — verify current AMH category-style guidance).
2. Do not assume “her doctor knows” without checking — transcription and multi-prescriber errors happen.
3. For lactation, assess infant risk, timing, and safer alternatives using AMH.
4. If risk is material and unaddressed, withhold and contact the prescriber urgently.

Using the AMH under restricted open-book conditions

In the Intern Written Examination you may take one paper AMH (and one paper APF). Efficient AMH use is a clinical skill:

• Go to the monograph for dose, contraindications, precautions, interactions highlights, and pregnancy/breastfeeding notes.
• Use class information when comparing therapeutic options.
• Check appendices/tables you have tabbed for renal dosing, interactions, or pregnancy themes (follow exam tab rules).
• Prefer AMH over memory for edge-case doses and interaction severity.
• APF supports counselling phrases, cautionary advisory labels, and practice guidance that complements AMH clinical monographs.

Do not spend the whole item hunting obscure footnotes if the stem already gives enough to identify a high-risk allergy or obvious overdose.

Prioritising clinically significant issues under time pressure

Dispensing is busy; the exam is timed. Use a harm-based triage:

1. Immediate harm if supplied wrong — anaphylaxis history to that drug, major pregnancy contraindication, anticoagulant duplication, ten-fold dose error, wrong patient.
2. High probability of serious harm — major PK interaction with narrow index drug, severe renal dose error, opioid + sedative stack without plan.
3. Moderate issues — suboptimal duration, missing monitoring plan, minor duplication.
4. Optimisation and counselling — adherence aids, lifestyle, device technique, minor food interactions.

Address tier 1–2 before supply. Tier 3 often needs prescriber contact the same day. Tier 4 can often be managed with counselling and follow-up documentation if the medicine is otherwise appropriate.

Integrated clinical checklist (after legal evaluation)

1. Indication plausible?
2. Dose appropriate for age/weight/renal/hepatic status?
3. Allergy/ADR history clear?
4. Pregnancy/lactation relevant?
5. Contraindications present?
6. Significant PK/PD interactions?
7. Exact or therapeutic duplication?
8. Monitoring required and feasible?
9. Patient able to use the form/device?
10. If any critical “no”, contact prescriber or withhold

Worked thinking pattern (exam stem style)

A 78-year-old with eGFR 25 mL/min presents a new prescription for a renally cleared medicine at full standard adult dose, plus an existing ACE inhibitor and regular NSAID for osteoarthritis. Even if the prescription is legally perfect, clinical appropriateness fails on renal dosing and nephrotoxic combination risk. Priority actions: withhold or urgently clarify dose, raise the NSAID + ACEI + low GFR concern, document, and propose safer alternatives or monitoring — not “dispense as written because the signature is valid.”

Bottom line for Standard 3.2.3

Clinical appropriateness converts dispensing from product supply into medication management. The Intern Written Examination rewards candidates who can spot the issue that actually threatens the patient, use AMH efficiently, and choose contact/withhold/supply-with-plan options in the right order.